Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily versus twice-daily duloxetine after total knee arthroplasty
ChiCTR2600135799Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of duloxetine in postoperative pain and knee osteoarthritis (OA) (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Pain level, Joint function and 1 more. Started Jun 2025; status: completed.
02
Drugs
duloxetine
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2600135799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135799.